CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only country among developed nations where insurance coverage is being debated.

Sheldon Ekirch was diagnosed with small fiber neuropathy, a condition that makes her limbs and muscles feel as if they're on ...

Cigna (CI) CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only country among developed nations where insurance coverage is being debated.

Cigna is positioned to benefit from utilization normalization and aims for 10%-14% annual EPS growth. See why I rate CI stock a buy at current prices.

The Cigna Group (NYSE:CI – Get Free Report) has been assigned a consensus rating of “Buy” from the seventeen research firms that are presently covering the firm, Ratings reports. Two research analysts ...